BioMaxima S.A. (FRA:944)

BioMaxima Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 23, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12	10	16	23	25	26
Market Cap Growth	-21.29%	-33.82%	-30.31%	-8.23%	-5.07%	730.84%
Enterprise Value	16	13	18	20	27	28
Last Close Price	2.48	2.16	3.46	5.07	5.20	-
PE Ratio	80.61	83.86	117.49	3.68	11.09	15.00
PS Ratio	0.89	0.85	1.47	0.74	1.44	1.95
PB Ratio	1.12	0.95	1.47	2.03	3.89	6.00
P/TBV Ratio	1.13	0.95	1.48	2.05	3.96	6.18
P/FCF Ratio	227.45	-	-	3.91	-	56.98
P/OCF Ratio	26.01	-	43.25	2.87	-	30.01
EV/Sales Ratio	1.13	1.06	1.64	0.66	1.54	2.08
EV/EBITDA Ratio	13.57	13.04	30.92	2.58	8.06	11.65
EV/EBIT Ratio	49.77	43.63	380.60	2.71	8.91	13.59
EV/FCF Ratio	292.70	-	-	3.48	-	60.91
Debt / Equity Ratio	0.34	0.31	0.27	0.11	0.59	0.63
Debt / EBITDA Ratio	3.25	3.19	4.90	0.16	1.13	1.14
Debt / FCF Ratio	69.44	-	-	0.21	-	5.94
Net Debt / Equity Ratio	0.32	0.29	0.24	-0.13	0.49	0.40
Net Debt / EBITDA Ratio	3.21	3.19	4.59	-0.19	0.95	0.74
Net Debt / FCF Ratio	64.59	-5.66	-0.69	-0.26	-3.09	3.84
Asset Turnover	-	0.70	0.63	2.11	1.44	1.35
Inventory Turnover	-	2.11	1.96	6.55	3.70	3.52
Quick Ratio	0.71	0.70	0.96	2.13	1.13	0.88
Current Ratio	1.41	1.49	2.19	3.30	1.93	1.94
Return on Equity (ROE)	-	1.14%	1.18%	70.75%	41.74%	43.75%
Return on Assets (ROA)	-	1.07%	0.17%	32.00%	15.57%	12.88%
Return on Invested Capital (ROIC)	2.15%	2.15%	0.39%	63.29%	30.67%	27.85%
Return on Capital Employed (ROCE)	2.30%	2.20%	0.30%	55.00%	30.60%	27.10%
Earnings Yield	1.24%	1.19%	0.85%	27.15%	9.01%	6.67%
FCF Yield	0.44%	-5.40%	-23.95%	25.55%	-4.06%	1.75%
Dividend Yield	-	-	-	2.11%	1.88%	-
Payout Ratio	-	-	357.85%	6.74%	10.71%	-
Buyback Yield / Dilution	-0.01%	2.89%	3.16%	0.52%	-4.45%	-15.05%
Total Shareholder Return	-0.01%	2.89%	3.16%	2.62%	-2.56%	-15.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.